MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-TS-09-0010818
Telisto Pharmaceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.93 Cr
▲ 129% YoY
Net profit · FY 2025
₹5.21 Lakh
Net margin 2.7%
EBITDA · FY 2025
₹7.36 Lakh
EBITDA margin 3.8%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹50 Lakh
Secured borrowings
Company age
6 yrs
Est. 2020
Employees · EPFO
19
Provident fund records
About Telisto Pharmaceuticals Private Limited
Data last updated:
Telisto Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 December 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U52100TG2020PTC146905. Its GSTIN is 36AAICT2982P1ZI (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Ravi Bellamkonda and Naga Malleswara Rao Rayapati.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No – 10 – 114/17 Satyanarayana Colony Nagaram, Hyderabad, Telangana, India – 500083.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.93 Cr, a growth of 129% compared to the previous year. For the same year it recorded a net profit of ₹5.21 Lakh (net margin 2.7%) and EBITDA of ₹7.36 Lakh (EBITDA margin 3.8%).
The company has about 19 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹50 Lakh on record.
Telisto Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0010818). For more details, the company can be reached via its website telistopharma.com.
Company details
CIN U52100TG2020PTC146905
Registration Number 146905
Incorporation Date 16 December 2020
ROC Hyderabad
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-TS-09-0010818
Recognitions & Rankings of Telisto Pharmaceuticals
Contact details
Telisto Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is telistopharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressH.No – 10 – 114/17 Satyanarayana Colony Nagaram, Hyderabad, Telangana, India – 500083
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Telisto Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Telisto Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Telisto Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Telisto Pharmaceuticals Private Limited, buy the company report.
Financials of Telisto Pharmaceuticals Private Limited
FY 2025 filings availableTelisto Pharmaceuticals Private Limited reported revenue of ₹1.93 Cr (up 129% YoY) for FY 2025.
Revenue · FY 2025
₹1.93 Cr ▲ 129%
Net profit · FY 2025
₹5.21 Lakh margin 2.7%
EBITDA · FY 2025
₹7.36 Lakh margin 3.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 129%
EBITDA CAGR growth
1 year
▲ 187%
3 years · compounded
▲ 53%
Revenue rose 129% in the latest year. EBITDA rose 187% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.36 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.21 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.8% | ||||
| Net Profit Margin | 2.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Telisto Pharmaceuticals Private Limited, buy the company report.
Board of directors of Telisto Pharmaceuticals Private Limited
Telisto Pharmaceuticals has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravi Bellamkonda Also directs: Akamei Pharmaceuticals Private Limited | Director | 03 Feb 2022 | 4 Years 9 Months | Current |
| Naga Malleswara Rao Rayapati | Director | 16 Dec 2020 | 5 Years 10 Months | Current |
| Pavani Koritala | Director | 16 Dec 2020 | 5 Years 10 Months | Current |
Peer comparison
Telisto Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| JMD Pharmaceuticals Private Limited | ₹1.95 Cr (FY 2025) | 33.0% | Bareilly, Uttar Pradesh, India | |||
| Ventude Pharmaceuticals Private Limited | ₹1.94 Cr (FY 2025) | 11.0% | Jaipur, Rajasthan, India | |||
| Telisto Pharmaceuticals Private Limitedthis company | ₹1.93 Cr (FY 2025) | ₹5.21 Lakh | 2.7% | 129.0% | 19 | Hyderabad, Telangana, India |
| Dashak Pharmaceuticals Private Limited | ₹1.93 Cr (FY 2024) | 9.0% | Chandigarh U.T, Chandigarh, India | |||
| Markwell Pharmaceuticals Private Limited | ₹1.91 Cr (FY 2024) | -1.0% | Agra, Uttar Pradesh, India | |||
| White Maple Pharmaceuticals Private Limited | ₹1.9 Cr (FY 2025) | -12.0% | Dibrugarh, Assam, India | |||
| Morksons Pharmaceuticals (India) Private Limited | ₹1.9 Cr (FY 2020) | -51.0% | New Delhi, Delhi, India |
To see the full peer comparison of Telisto Pharmaceuticals Private Limited, buy the company report.
Auditor
Telisto Pharmaceuticals Private Limited is audited by TAKKELLAPATI SYAM PRASAD for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| TAKKELLAPATI SYAM PRASAD | FY 2023 | 247665 |
Shareholding
The shareholding of Telisto Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Telisto Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹50 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Nov 2025 | 101190791 | Hdfc Bank Limited | ₹50 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Telisto Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Telisto Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Telisto Pharmaceuticals Private Limited has a workforce of 19 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
19
Active EPFO establishments
1
Employee growth
26.7%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 19 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 |
To see the full employee and EPFO history of Telisto Pharmaceuticals Private Limited, buy the company report.
GST
Telisto Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAICT2982P1ZI | Telangana | Active | 26 Mar 2021 |
| 37AAICT2982P1ZG | Andhra Pradesh | Active | 23 Sep 2024 |
To see the full GST registrations and return filing status of Telisto Pharmaceuticals Private Limited, buy the company report.
Recent activity
Telisto Pharmaceuticals Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Ravi Bellamkonda was appointed as Director on 03 Feb 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 50.00 Lakh with Charge ID 101190791 was registered on 08 Nov 2025.
AGM
Telisto Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Telisto Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Ravi Bellamkonda was appointed as Director.
Appointed
Naga Malleswara Rao Rayapati was appointed as Director.
Appointed
Pavani Koritala was appointed as Director.
Incorporation
16 Dec 2020
Telisto Pharmaceuticals Private Limited was registered on 16 Dec 2020 with Roc Hyderabad & aged 5 years 10 months as per MCA records.
Frequently asked questions
Telisto Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 December 2020 (6+ years old) and is registered under CIN U52100TG2020PTC146905.
Telisto Pharmaceuticals has 3 current directors:
- Ravi Bellamkonda - Director
- Naga Malleswara Rao Rayapati - Director
- Pavani Koritala - Director
The latest financial statements of Telisto Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Telisto Pharmaceuticals is 36AAICT2982P1ZI, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AAICT2982P1ZG (Andhra Pradesh).
The CIN (Corporate Identification Number) of Telisto Pharmaceuticals is U52100TG2020PTC146905. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Telisto Pharmaceuticals was incorporated on 16 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Telisto Pharmaceuticals by revenue are JMD Pharmaceuticals Private Limited, Ventude Pharmaceuticals Private Limited, Dashak Pharmaceuticals Private Limited, Markwell Pharmaceuticals Private Limited, White Maple Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Ravi Bellamkonda was appointed as Director on 03 Feb 2022. Naga Malleswara Rao Rayapati was appointed as Director on 16 Dec 2020. Pavani Koritala was appointed as Director on 16 Dec 2020.
Yes, Telisto Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-09-0010818).
Telisto Pharmaceuticals can be reached through the website telistopharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Telisto Pharmaceuticals is at H.No – 10 – 11417 Satyanarayana Colony Nagaram, Hyderabad, Telangana, India – 500083.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages